Literature DB >> 24861053

Precision genome editing: a small revolution for glycobiology.

Catharina Steentoft1, Eric P Bennett2, Katrine T-B G Schjoldager2, Sergey Y Vakhrushev2, Hans H Wandall2, Henrik Clausen2.   

Abstract

Precise and stable gene editing in mammalian cell lines has until recently been hampered by the lack of efficient targeting methods. While different gene silencing strategies have had tremendous impact on many biological fields, they have generally not been applied with wide success in the field of glycobiology, primarily due to their low efficiencies, with resultant failure to impose substantial phenotypic consequences upon the final glycosylation products. Here, we review novel nuclease-based precision genome editing techniques enabling efficient and stable gene editing, including gene disruption, insertion, repair, modification and deletion. The nuclease-based techniques comprised of homing endonucleases, zinc finger nucleases, transcription activator-like effector nucleases, as well as the RNA-guided clustered regularly interspaced short palindromic repeat/Cas nuclease system, all function by introducing single or double-stranded breaks at a defined genomic sequence. We here compare and contrast the different techniques and summarize their current applications, highlighting cases from the field of glycobiology as well as pointing to future opportunities. The emerging potential of precision gene editing for the field is exemplified by applications to xenotransplantation; to probing O-glycoproteomes, including differential O-GalNAc glycoproteomes, to decipher the function of individual polypeptide GalNAc-transferases, as well as for engineering Chinese Hamster Ovary host cells for production of improved therapeutic biologics.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  GALNT; SimpleCell; glycoengineering; isogenic cell system

Mesh:

Year:  2014        PMID: 24861053     DOI: 10.1093/glycob/cwu046

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  25 in total

Review 1.  Glycosylation of solute carriers: mechanisms and functional consequences.

Authors:  Nis Borbye Pedersen; Michael C Carlsson; Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2015-09-18       Impact factor: 3.657

2.  An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells.

Authors:  Yoshiki Narimatsu; Hiren J Joshi; Rebecca Nason; Julie Van Coillie; Richard Karlsson; Lingbo Sun; Zilu Ye; Yen-Hsi Chen; Katrine T Schjoldager; Catharina Steentoft; Sanae Furukawa; Barbara A Bensing; Paul M Sullam; Andrew J Thompson; James C Paulson; Christian Büll; Gosse J Adema; Ulla Mandel; Lars Hansen; Eric Paul Bennett; Ajit Varki; Sergey Y Vakhrushev; Zhang Yang; Henrik Clausen
Journal:  Mol Cell       Date:  2019-06-18       Impact factor: 17.970

Review 3.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

4.  Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery.

Authors:  Diana Campos; Daniela Freitas; Joana Gomes; Ana Magalhães; Catharina Steentoft; Catarina Gomes; Malene B Vester-Christensen; José Alexandre Ferreira; Luis P Afonso; Lúcio L Santos; João Pinto de Sousa; Ulla Mandel; Henrik Clausen; Sergey Y Vakhrushev; Celso A Reis
Journal:  Mol Cell Proteomics       Date:  2015-03-26       Impact factor: 5.911

5.  Engineered CHO cells for production of diverse, homogeneous glycoproteins.

Authors:  Zhang Yang; Shengjun Wang; Adnan Halim; Morten Alder Schulz; Morten Frodin; Shamim H Rahman; Malene B Vester-Christensen; Carsten Behrens; Claus Kristensen; Sergey Y Vakhrushev; Eric Paul Bennett; Hans H Wandall; Henrik Clausen
Journal:  Nat Biotechnol       Date:  2015-07-20       Impact factor: 54.908

Review 6.  Using glyco-engineering to produce therapeutic proteins.

Authors:  Martina Dicker; Richard Strasser
Journal:  Expert Opin Biol Ther       Date:  2015-07-14       Impact factor: 4.388

7.  A validated collection of mouse monoclonal antibodies to human glycosyltransferases functioning in mucin-type O-glycosylation.

Authors:  Catharina Steentoft; Zhang Yang; Shengjun Wang; Tongzhong Ju; Malene B Vester-Christensen; María F Festari; Sarah L King; Kelley Moremen; Ida S B Larsen; Christoffer K Goth; Katrine T Schjoldager; Lars Hansen; Eric P Bennett; Ulla Mandel; Yoshiki Narimatsu
Journal:  Glycobiology       Date:  2019-08-20       Impact factor: 4.313

Review 8.  Oligosaccharide Synthesis and Translational Innovation.

Authors:  Larissa Krasnova; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2019-02-18       Impact factor: 15.419

Review 9.  Emerging patterns of tyrosine sulfation and O-glycosylation cross-talk and co-localization.

Authors:  Akul Y Mehta; Jamie Heimburg-Molinaro; Richard D Cummings; Christoffer K Goth
Journal:  Curr Opin Struct Biol       Date:  2020-01-09       Impact factor: 6.809

10.  The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.

Authors:  Zhang Yang; Adnan Halim; Yoshiki Narimatsu; Hiren Jitendra Joshi; Catharina Steentoft; Katrine Ter-Borch Gram Schjoldager; Morten Alder Schulz; Natalie R Sealover; Kevin J Kayser; Eric Paul Bennett; Steven B Levery; Sergey Y Vakhrushev; Henrik Clausen
Journal:  Mol Cell Proteomics       Date:  2014-08-04       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.